Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma
Kimberley Jones, Frank Vari, Colm Keane, Pauline Crooks, Jamie P Nourse, Louise A Seymour, David Gottlieb, David Ritchie, Devinder Gill, Maher K Gandhi
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2013
D. Gottlieb has a commercial research grant from Celgene and honoraria from speakers' bureau from Gilead. No potential conflicts of interest were disclosed by the other authors.This was an Australasian Leukaemia & Lymphoma Group sponsored study. The authors thank Susan Arnold for her assistance with data collection and Clay Winterford for immunohistochemistry staining.Work in the Clinical Immunohaematology laboratory is sponsored by the National Health and Medical Research Council (Australia), Leukaemia Foundation (Australia), Cancer Council of Queensland, and Queensland Office of Health and Medical Research. K. L. Jones is supported by the Leukaemia Foundation (Australia), the Australian Centre for Vaccine Development, and QIMR.